The new Changzhou, China-based site adds transition metal catalyst-screening technology to STA’s small molecule process development and manufacturing platform.
Almac says the completion of a Knowledge Transfer Partnership (KTP) has aided biocatalysis development offering clients an array of streamlined processes.
DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has announced the launch of InnoSyn route scouting services, meeting pharma needs to outsource process development R&D.
Codexis’ enzymatic biocatalysis technology offers numerous processing and cost advantages for API and chemical intermediate manufacture says Dishman CRAMS unit president Nick Green.
UK-based Reaxa and Switzerland’s RohnerChem have teamed up to develop the former’s EnCat catalyst technology for industrial applications in the API and drug manufacturing sector.
Biocatalysis expert Codexis has acquired BioCatalytics for an
undisclosed amount to strengthen its off-the-shelf biocatalyst
portfolio and give itself a larger 'window to the market'.
British chemical products and technologies firm Reaxa has launched
a new encapsulated catalyst for market trials. Platinum EnCat is a
platinum nanoparticle catalyst encapsulated within polymer beads,
intended for the hydrogenation...
A key study performed by US scientists has uncovered detailed
structural changes, which a catalytic enzyme undergoes in order to
carry out its biological function. The findings challenge
traditional hypothesis and may aid in future...
British catalyst technologies firm Reaxa has slashed the prices of
its encapsulated catalysts by two-thirds following increased demand
for production scale quantities in pharma applications.
Degussa have discovered a catalyst that improves the efficiency of
reductive carbonylation reactions and will provide greater access
to new active pharmaceutical ingredients (APIs).
Avecia spin-off, Reaxa, has announced that Umicore has taken a 21
per cent stake in a move that underlines Reaxa's business strategy
in looking at joint R&D, new product development and toll
manufacturing agreements.
One of the biggest challenges in catalysed chemical reactions is to
remove and recycle the catalyst once the process is complete. A new
approach, using Teflon, could make recovery simpler and cut down on
the use of solvents, writes...
Fine chemicals company Rohner is to work together with
Switzerland's Solvias on the provision of development and
manufacturing services for complex active pharmaceutical
ingredients (APIs).
Degussa Homogeneous Catalysts, an internal start-up company
operating as part of the Degussa chemical group, introduced a new
family of ligands at the CPhI meeting.
Irish start-up Celtic Catalysts believes it can tackle two of the
major obstacles holding back the use of catalysts to make chiral
drugs - the strong patent positions of existing players and
difficulties in scale-up - with its platform...
The global market for nanocatalysts will amount to $3.7 billion in
2004 and is expected to reach $5.0 billion in 2009, according to
soon-to-be-released market research.
Eastman Chemical has extended its agreement with Johnson Matthey
subsidiary Alfa Aesar in a move that will for the first time make
its proprietary BoPhoz catalyst ligands available in research
quantities.
The completion of Degussa's reorganisation of its fine chemicals
activities into two separate business units heralds a raft of new
projects at the company.